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 Dear Editor, 
about one year ago we had an experience that brought us to look for and appreciate the interesting paper from Steffen et al (1) about the 
underestimation of cholera cases in developed countries. 
On the evening of 23 October 2017, a 35-year-old man presented to the Emergency Department of a peripherical hospital in the neighbour of Milan 
(Sesto San Giovanni), Italy complaining of a 3-day history of watery diarrhoea and  vomiting preceded by sensation of fever. The patient reported no 
blood or mucous in the stool. Up to this point his history was not different from many other multiethnic patients waiting in the same room, but there 
was a particularity, he had just returned (October 22) from his annual family visit to the country of origin (from August 22) in Dhaka, Bangladesh. 
During the travel he consumed local food and drank tap water as he used to do every visit before and no direct contact with sick individuals was 
reported. His past medical history was unremarkable and he has been living and working in Italy since 2009. He didn't perceived any at risk behaviour 
and he did never look for travel medicine consultation before his annual visit to the homeland.  
At presentation the patient was alert, afebrile, anuric with evidence of severe dehydration. On admission, blood laboratory analysis showed 
leukocytosis (white blood cell count of 21,380/µL; norm :4,000-10,000/µL), haemoglobin 20 g/dL (norm male: 14.2-17.2), haematocrit 64% (norm 
male: 43-52%), high serum creatinine level (3.08 mg/dL; norm: 0.6-1.40 mg/dL) and severe metabolic acidosis (pH 7.047; norm: 7.35-7.45) with low 
bicarbonate (10 mmol/L; norm:22-26 mmol/L) and borderline low sodium (135 mmol/L ; norm: 135-145 mmol/L) and potassium (3.5 mmol/L; norm 
3,5-5.1 mmol/L). A chest X-ray was normal and an abdomen ultrasound showed bowel distension. Extensive parenteral fluid and electrolyte 
replacement with a central line was started together with empiric antibiotic therapy with ciprofloxacin (200 mg twice day) and metronidazole (500 mg 
every 6 hours). After about 12 hours in the emergency department (ED) where he received sub-intensive care the patient was hospitalized in the local 
internal medicine ward with contact isolation.  
It's interesting to highlight that it took five days from the presentation at ED to the microbiological diagnosis because of the low suspect index. Once 
that the cholera suspect was formulated the local microbiology department lacked the proper grow medium and the expertise to search for Vibrio 
cholerae and the stool sample had to be transported to the Laboratory of Clinical Microbiology at L. Sacco Hospital where it was plated on Thiosulfate 
Citrate Bile Salts Sucrose agar (TCBS, Biomerieux, France) and incubated for 24 hours at 37°C. Vibrio cholerae was then identified at the species level 
and  tested for antimicrobial susceptibility. Full sensitivity to all standard antibiotics was recorded,  according to the European Committee on 
Antimicrobial Susceptibility Testing (EUCAST). The strain was sent to the Istituto Superiore di Sanità  for further typing, and the isolate was 
confirmed to be  V. cholerae O1 serotype Inaba. 
The case was reported to the Regional Health Authority and the patients was transferred to the Infectious Disease ward at Luigi Sacco hospital when 
the diarrhoea was almost resolved. He was discharged 6 days later with normal kidney and bowel function. Ciprofloxacin therapy was prosecuted for a 
total of 10 days due to the concomitant E. coli bacteraemia identified on admission. No secondary cases were identified from patient’s relatives. 
Although cholera remains a significant public health problem worldwide with major outbreaks occurring in Africa, Central America and South-East 
Asia, it is very infrequently reported among travellers and immigrants [2,3]. For instance , in the GeoSentinel study conducted from 1996 to 2011 to 
evaluate potentially life-threatening tropical diseases among western travellers no cases of cholera were reported among 3,666 patients [4]. The same 
GeoSentinel Network in a study from 2007 to 2011 of ill returned travellers (that included also VFRs) reported only 2 cases of cholera out of 3651 
patients presenting with gastrointestinal diseases [5]. In a retrospective study performed in France 129 cases of cholera were notified during a 32-years 
period (an average of 3.9 cases/year) but with a significant reduction in the period 2000-2005 [6]. A similar pathway is observed in the countries of the 
European Union were a total of 88 cases were notified between 2010 to 2014 with the lowest mean annual number registered in 2013 and 2014 [3]. 
Moreover, the rarity of encountering this imported disease is mirrored by the paucity of published cases in the literature in the last 24 years (Table 1). 
In conclusion, we have described a case of imported cholera diagnosed in Italy in 2017 discussing the clues that should help clinicians to suspect this 
infrequent and likely underestimate imported disease. This is particularly important because as observed in our case and reported by Tarantola and 
coworkers  diagnosis is increasingly made in nonteaching hospitals [6] where the suspect index for imported disease could be lower. 
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Table 1- Single case reports of imported cholera described in Europe and USA from 1994 to 2018 
Author/Ref Year Sex/Age Nationality Category 
of travel 
Country 
visited 
Country of 
observation 
V. 
cholerae 
type 
Signs & 
symptoms 
Laboratory 
exams 
Dialysis Antibiotic 
treatment 
Outcome 
Emeis/10 1994 F/15 Pakistani VFR Pakistan Germany O139 Watery 
diarrhoea, 
vomiting, 
shock 
Creatinine 
4.4 mg/dL; 
metabolic 
acidosis (pH 
7.21) 
No Tetracycline Recovery 
Leentvar-
Kuijpers/11 
1995 M/67 NR NA Holland* United 
Kingdom 
O1, El Tor, 
Ogawa 
Watery 
diarrhoea 
NR No Tetracycline Recovery 
Dalsgaard/12 1996 F/61 Vietnamese VFR VietNam Denmark O139 Watery 
diarrhoea 
NR No NR Recovery 
Schurmann/13 2002 M/36 Nigerian VFR§ Nigeria Germany O1, El Tor, 
Inaba 
Watery 
diarrhoea, 
vomiting, 
hypotension 
Creatinine 5 
mg/dL 
No NR Recovery 
Strumbelj/14 2005 M/20 Slovene Work Tunisia Slovenia Non-O1, 
non-O139 
Diarrhoea, 
vomiting, 
fever; liver 
and spleen 
abscesses 
NR No Ampicillin, 
doxycycline, 
ciprofloxacin 
Recovery 
Ciofi degli 
Atti/15 
2005 M/45 Senegalese VFR Senegal Italy O1, Ogawa Severe 
diarrhoea, 
metabolic 
acidosis, 
oliguria 
Creatinine 
9,5 mg/dL 
Yes (1 
session) 
Ciprofloxacin+ 
Metronidazole 
(3 days) 
Recovery 
Van Furth/16 2006 M/7 Indian VFR India The 
Netherlands 
O1, El Tor, 
Inaba 
Watery 
diarrhoea, 
lost of 
consciouness 
NR No NR Recovery 
De 
Schrijver/17 
2007 F/62 Belgian Traveller Turkey Belgium O1, El Tor, 
Inaba 
Severe 
watery 
diarrhoea, 
dehydration, 
metabolic 
acidosis, 
renal failure 
NR NR Quinolone Recovery 
 2007 F/67 Belgian Traveller Turkey Belgium O1, El Tor, 
Inaba 
NR NR NR Quinolone Recovery  
Reyes-
Corcho/18 
2012 M/76 African-
American 
VFR Haiti  USA  Watery 
diarrhoea, 
severe 
weakness, 
dizziness, 
muscle 
cramps, 
nausea, 
vomiting 
Leukocytosis 
(20.800 /µL); 
metabolic 
acidosis (pH 
7.16); low 
bicarbonate 
(16 mEq/L); 
hypokaliemia 
(3.1 mEq/L); 
creatinine 2.7 
mg/dL 
Yes (2 
sessions) 
Doxycycline 
300 mg per os 
Recovery 
Mascarello/19 2013 M/40 Italian Traveller Cuba Italy O1, El Tor, 
Ogawa 
Watery 
diarrhoea, 
severe 
weakness, 
muscle 
cramps, 
dizziness, 
abdominal 
pain, nausea, 
vomiting, 
weight loss 
(10 kg) 
Leucocytosis 
(16,800 /µL); 
creatinine 
5.69 mg/dL; 
low 
bicarbonate 
(11.3 
mmol/L); 
hypokaliemia 
(2.7 mEq/L); 
metabolic 
acidosis (pH 
7.16) 
Yes (1 
session) 
Ciprofloxacin 
200 mg x 2/day 
for 7 days 
Recovery 
Sachinwalla/20 2015 M/49 Haitian  VFR Haiti USA O1, Ogawa Nausea, 
vomiting, 
diarrhoea, 
abdominal 
pain 
Hemoglobin 
20 g/dL; 
Haematocrit 
59.8%; 
creatinine 4.4  
mg/dL; 
leucocytosis 
(11,500/µL) 
No Ciprofloxacin 3 
days 
Recovery 
Slesak/21 2016 M/56 German Business The 
Philippines 
Germany O1, El Tor, 
Ogawa 
Watery 
diarrhoea, 
hypotension, 
weight loss 
(5 kg), 
anuria 
Normal 
leucocytes 
(9860/µL); 
creatinine 4.4 
mg/dL 
No Doxycycline 
300 mg single 
dose 
Recovery 
Pougnet/22 2018 M/54 French Traveller India France O1, Ogawa Diarrhoea, 
vomiting, 
shock, 
Hemoglobin 
20.4 g/dL; 
Haematocrit 
No Ciprofloxacin Recovery 
weight loss 
(10 kg) 
57.1%; 
creatinine 
2.57 mg/dL 
VFR, visiting friends and relatives; NR, not reported; * Likely origin imported frozen coconut milk;  § Holiday in Nigeria 12 days before the onset of cholera (not compatible with 
the incubation period of the disease). Cholera probably contracted by handling a fresh fish imported from Nigeria. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
